{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:04:14Z","timestamp":1780524254820,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/leu.2009.136","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T09:40:05Z","timestamp":1247132405000},"page":"2139-2146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients"],"prefix":"10.1038","volume":"23","author":[{"given":"S","family":"Colucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Oranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F P","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Liso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Grano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"BFleu2009136_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.bone.2008.01.027","volume":"42","author":"CM Edwards","year":"2008","unstructured":"Edwards CM, Zhuang J, Mundy GR . The pathogenesis of the bone disease of multiple myeloma. Bone 2008; 42: 1007\u20131013.","journal-title":"Bone"},{"key":"BFleu2009136_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL . Osteoclast differentiation and activation. Nature 2003; 423: 337\u2013342.","journal-title":"Nature"},{"key":"BFleu2009136_CR3","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1182\/blood-2004-02-0474","volume":"104","author":"S Colucci","year":"2004","unstructured":"Colucci S, Brunetti G, Rizzi R, Zonno A, Mori G, Colaianni G et al. T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG\/TRAIL interaction. Blood 2004; 104: 3722\u20133730.","journal-title":"Blood"},{"key":"BFleu2009136_CR4","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1182\/blood-2002-04-1121","volume":"100","author":"N Giuliani","year":"2002","unstructured":"Giuliani N, Colla S, Sala R, Moroni M, Lazzaretti M, La Monica S et al. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. Blood 2002; 100: 4615\u20134621.","journal-title":"Blood"},{"key":"BFleu2009136_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/art.21731","volume":"54","author":"ME Miranda-Car\u00fas","year":"2006","unstructured":"Miranda-Car\u00fas ME, Benito-Miguel M, Balsa A, Cobo-Ib\u00e1\u00f1ez T, P\u00e9rez de Ayala C, Pascual-Salcedo D et al. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum 2006; 54: 1151\u20131164.","journal-title":"Arthritis Rheum"},{"key":"BFleu2009136_CR6","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1902\/jop.2005.76.10.1675","volume":"76","author":"G Brunetti","year":"2005","unstructured":"Brunetti G, Colucci S, Pignataro P, Coricciati M, Mori G, Cirulli N et al. T cells support the osteoclastogenesis in an in vitro model derived from human periodontitis patients. J Periodontol 2005; 76: 1675\u20131680.","journal-title":"J Periodontol"},{"key":"BFleu2009136_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/path.2153","volume":"212","author":"S Colucci","year":"2007","unstructured":"Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, Quarta L et al. Lymphocytes and synovial fluid fibroblasts support the osteoclastogenesis through RANKL, TNF-alpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol 2007; 212: 47\u201355.","journal-title":"J Pathol"},{"key":"BFleu2009136_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1096\/fj.04-1823fje","volume":"19","author":"I Roato","year":"2005","unstructured":"Roato I, Grano M, Brunetti G, Colucci S, Mussa A, Bertetto O et al. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement. FASEB J 2005; 19: 228\u2013230.","journal-title":"FASEB J"},{"key":"BFleu2009136_CR9","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL . TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000; 106: 1481\u20131488.","journal-title":"J Clin Invest"},{"key":"BFleu2009136_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.20050978","volume":"202","author":"N Kim","year":"2005","unstructured":"Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 2005; 202: 589\u2013595.","journal-title":"J Exp Med"},{"key":"BFleu2009136_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1210\/endo.143.3.8701","volume":"143","author":"K Fuller","year":"2002","unstructured":"Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ . TNF alpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002; 143: 1108\u20131118.","journal-title":"Endocrinology"},{"key":"BFleu2009136_CR12","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1016\/S0021-9258(19)61511-5","volume":"275","author":"Y Abu-Amer","year":"2000","unstructured":"Abu-Amer Y, Erdmann J, Kollias G, Alexopoulou L, Ross FP, Teitelbaum SL . Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem 2000; 275: 27307\u201327310.","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"BFleu2009136_CR13","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1038\/sj.cdd.4401403","volume":"11","author":"CR Yang","year":"2004","unstructured":"Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL, Lin WW . Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte\/macrophage lineage precursor cells. Cell Death Differ 2004; 11 (Suppl 1): S97\u2013S107.","journal-title":"Cell Death Differ"},{"key":"BFleu2009136_CR14","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1074\/jbc.M603070200","volume":"282","author":"CH Tang","year":"2007","unstructured":"Tang CH, Hsu TL, Lin WW, Lai MZ, Yang RS, Hsieh SL et al. Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice. J Biol Chem 2007; 282: 2346\u20132354.","journal-title":"J Biol Chem"},{"key":"BFleu2009136_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/25387","volume":"396","author":"RM Pitti","year":"1998","unstructured":"Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998; 396: 699\u2013703.","journal-title":"Nature"},{"key":"BFleu2009136_CR16","first-page":"2759","volume":"61","author":"W Roth","year":"2001","unstructured":"Roth W, Isenmann S, Nakamura M, Platten M, Wick W, Kleihues P et al. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res 2001; 61: 2759\u20132765.","journal-title":"Cancer Res"},{"key":"BFleu2009136_CR17","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1073\/pnas.97.3.1230","volume":"97","author":"C Bai","year":"2000","unstructured":"Bai C, Connolly B, Metzker ML, Hilliard CA, Liu X, Sandig V et al. Overexpression of M68\/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA 2000; 97: 1230\u20131235.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009136_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0304-3835(00)00567-X","volume":"160","author":"K Ohshima","year":"2000","unstructured":"Ohshima K, Haraoka S, Sugihara M, Suzumiya J, Kawasaki C, Kanda M et al. Amplification and expression of a decoy receptor for Fas ligand (DcR3) in virus (EBV or HTLV-1) associated lymphomas. Cancer Lett 2000; 160: 89\u201397.","journal-title":"Cancer Lett"},{"key":"BFleu2009136_CR19","doi-asserted-by":"publisher","first-page":"13733","DOI":"10.1074\/jbc.274.20.13733","volume":"274","author":"KY Yu","year":"1999","unstructured":"Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BX . A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999; 274: 13733\u201313736.","journal-title":"J Biol Chem"},{"key":"BFleu2009136_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1074-7613(02)00283-2","volume":"16","author":"TS Migone","year":"2002","unstructured":"Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B et al. TL1A is a TNF-like ligand for DR3 and TR6\/DcR3 and functions as a T cell costimulator. Immunity 2002; 16: 479\u2013492.","journal-title":"Immunity"},{"key":"BFleu2009136_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121: 749\u2013757.","journal-title":"Br J Haematol"},{"key":"BFleu2009136_CR22","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blad\u00e9 J et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412\u20133420.","journal-title":"J Clin Oncol"},{"key":"BFleu2009136_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ygyno.2008.07.012","volume":"111","author":"JP Connor","year":"2008","unstructured":"Connor JP, Felder M . Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance. Gynecol Oncol 2008; 111: 330\u2013335.","journal-title":"Gynecol Oncol"},{"key":"BFleu2009136_CR24","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2009136_CR25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s10495-007-0095-3","volume":"12","author":"S Colucci","year":"2007","unstructured":"Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, Pignataro P et al. The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis. Apoptosis 2007; 12: 1623\u20131632.","journal-title":"Apoptosis"},{"key":"BFleu2009136_CR26","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.3748\/wjg.v11.i38.5926","volume":"11","author":"HW Shen","year":"2005","unstructured":"Shen HW, Gao SL, Wu YL, Peng SY . Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis. World J Gastroenterol 2005; 11: 5926\u20135930.","journal-title":"World J Gastroenterol"},{"key":"BFleu2009136_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ijc.11170","volume":"106","author":"S Tsuji","year":"2003","unstructured":"Tsuji S, Hosotani R, Yonehara S, Masui T, Tulachan SS, Nakajima S et al. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer 2003; 106: 17\u201325.","journal-title":"Int J Cancer"},{"key":"BFleu2009136_CR28","first-page":"311","volume":"18","author":"A Elnemr","year":"2001","unstructured":"Elnemr A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Fujimura T et al. Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway. Int J Oncol 2001; 18: 311\u2013316.","journal-title":"Int J Oncol"},{"key":"BFleu2009136_CR29","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/emboj\/17.6.1675","volume":"17","author":"C Scaffidi","year":"1998","unstructured":"Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. Two CD95 (APO-1\/Fas) signaling pathways. EMBO J 1998; 17: 1675\u20131687.","journal-title":"EMBO J"},{"key":"BFleu2009136_CR30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/art.22494","volume":"56","author":"S Hayashi","year":"2007","unstructured":"Hayashi S, Miura Y, Nishiyama T, Mitani M, Tateishi K, Sakai Y et al. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Arthritis Rheum 2007; 56: 1067\u20131075.","journal-title":"Arthritis Rheum"},{"key":"BFleu2009136_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1357-4310(97)01191-X","volume":"4","author":"S Strand","year":"1998","unstructured":"Strand S, Galle PR . Immune evasion by tumours: involvement of the CD95 (APO-1\/Fas) system and its clinical implications. Mol Med Today 1998; 4: 63\u201368.","journal-title":"Mol Med Today"},{"key":"BFleu2009136_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH746>3.0.CO;2-K","volume":"193","author":"CT Chou","year":"2001","unstructured":"Chou CT, Yang JS, Lee MR . Apoptosis in rheumatoid arthritis - expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 2001; 193: 110\u2013116.","journal-title":"J Pathol"},{"key":"BFleu2009136_CR33","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.1158\/0008-5472.CAN-08-0402","volume":"68","author":"N Giuliani","year":"2008","unstructured":"Giuliani N, Lisignoli G, Colla S, Lazzaretti M, Storti P, Mancini C et al. CC-Chemokine ligand 20\/macrophage inflammatory protein-3alpha and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions. Cancer Res 2008; 68: 6840\u20136850.","journal-title":"Cancer Res"},{"key":"BFleu2009136_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.leukres.2007.12.018","volume":"2","author":"I El Hajj Dib","year":"2008","unstructured":"El Hajj Dib I, M\u00e9lanie G, Valery S, Romuald M, Michel B, Kamel S . Multiple myeloma cells directly stimulate bone resorption in vitro by down-regulating mature osteoclast apoptosis. Leuk Res 2008; 2: 1279\u20131287.","journal-title":"Leuk Res"},{"key":"BFleu2009136_CR35","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/art.21821","volume":"54","author":"JR Edwards","year":"2006","unstructured":"Edwards JR, Sun SG, Locklin R, Shipman CM, Adamopoulos IE, Athanasou NA et al. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum 2006; 54: 1451\u20131462.","journal-title":"Arthritis Rheum"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2009136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009136","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:30:52Z","timestamp":1648729852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2009136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,9]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BFleu2009136"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.136","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,9]]},"assertion":[{"value":"9 December 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}